DeepMed Research

National Cancer Center Korea

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Subsidiary

Established: 1989-01-01

Employees: -

Market Cap: -

Website: http://www.ncc.re.kr

Clinical Trials

Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma

Phase 2

Conditions: Stomach Neoplasms

Interventions: Drug: S-1,oxaliplatin

First Posted Date: 2007-08-13

Last Posted Date: 2008-01-07

Lead Sponsor: National Cancer Center, Korea

Target Recruit Count: 198

Registration Number: NCT00515190

Locations: 🇰🇷
National Cancer Center Korea, Goyang, Gyeonggi, Korea, Republic of

A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer

Phase 2

Completed

Conditions: Stomach Neoplasms

First Posted Date: 2007-08-08

Last Posted Date: 2009-09-18

Lead Sponsor: National Cancer Center, Korea

Target Recruit Count: 44

Registration Number: NCT00512681

Locations: 🇰🇷
National Cancer Center Korea, Goyang, Gyeonggi, Korea, Republic of

Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer

Phase 2

Terminated

Conditions: Colorectal Neoplasms
Secondary
Drug Therapy, Combination

First Posted Date: 2007-07-25

Last Posted Date: 2007-07-25

Lead Sponsor: National Cancer Center, Korea

Target Recruit Count: 37

Registration Number: NCT00506168

Locations: 🇰🇷
National Cancer Center Korea, Goyang, Gyeonggi, Korea, Republic of

Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer

Phase 2

Conditions: Rectal Neoplasm
Neoadjuvant Therapy

First Posted Date: 2007-07-25

Last Posted Date: 2007-07-25

Lead Sponsor: National Cancer Center, Korea

Target Recruit Count: 48

Registration Number: NCT00506623

Locations: 🇰🇷
National Cancer Center Korea, Goyang, Gyeonggi, Korea, Republic of

Preoperative Chemoradiotherapy With Cetuximab in Rectal Cancer

Phase 2

Conditions: Rectal Neoplasms
Neoadjuvant Treatment

First Posted Date: 2007-07-25

Last Posted Date: 2007-07-25

Lead Sponsor: National Cancer Center, Korea

Target Recruit Count: 40

Registration Number: NCT00506844

Locations: 🇰🇷
National Cancer Center Korea, Goyang, Gyeonggi, Korea, Republic of
🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷
Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Korea, Republic of

and more 1 locations

Phase II Study of Irinotecan,Oxaliplatin Plus TS-1 in Untreated Metastatic Colorectal Cancer

Phase 2

Conditions: Colorecal Neoplasms
Secondary

First Posted Date: 2007-07-25

Last Posted Date: 2007-07-25

Lead Sponsor: National Cancer Center, Korea

Target Recruit Count: 42

Registration Number: NCT00506571

Locations: 🇰🇷
National Cancer Center Korea, Goyang, Gyeonggi, Korea, Republic of

Study of Genetic Polymorphisms of Drug Transporters and Orphan Nuclear Receptors on Treatment Effects of Irinotecan

Not Applicable

Conditions: Colorectal Neoplasms
Secondary

First Posted Date: 2007-07-25

Last Posted Date: 2007-07-25

Lead Sponsor: National Cancer Center, Korea

Target Recruit Count: 100

Registration Number: NCT00507143

Locations: 🇰🇷
National Cancer Center Korea, Goyang, Gyeonggi, Korea, Republic of

A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy

Phase 1

Conditions: Colorectal Neoplasm
Gastric Neoplasm
Secondary

First Posted Date: 2007-07-25

Last Posted Date: 2007-07-25

Lead Sponsor: National Cancer Center, Korea

Target Recruit Count: 23

Registration Number: NCT00506207

Locations: 🇰🇷
National Cancer Center Korea, Goyang, Gyeonggi, Korea, Republic of

Randomized Prospective Trial for Laparoscopic vs Open Resection for Rectal Cancer

Phase 3

Conditions: Rectal Cancer

Interventions: Procedure: open rectal resection
Procedure: laparoscopic rectal resection

First Posted Date: 2007-05-08

Last Posted Date: 2012-08-17

Lead Sponsor: National Cancer Center, Korea

Target Recruit Count: 340

Registration Number: NCT00470951

Locations: 🇰🇷
National Cancer Center, Korea, Goyang, Gyeonggi, Korea, Republic of

First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker

Phase 3

Completed

Conditions: Lung Cancer

Interventions: Procedure: chemotherapy
Drug: Gefitinib

First Posted Date: 2007-04-04

Last Posted Date: 2010-10-25

Lead Sponsor: National Cancer Center, Korea

Target Recruit Count: 315

Registration Number: NCT00455936

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
🇰🇷
National Cancer Center, Korea, Goyang-si, Gyenggi-do, Korea, Republic of
🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy